T
Theodore R. Levin
Researcher at University of California, San Francisco
Publications - 10
Citations - 403
Theodore R. Levin is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Public health & Colonoscopy. The author has an hindex of 5, co-authored 10 publications receiving 387 citations. Previous affiliations of Theodore R. Levin include Kaiser Permanente.
Papers
More filters
Journal ArticleDOI
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
Jonathan P. Terdiman,James R. Gum,Peggy Conrad,Glenn Miller,Vivian Weinberg,Suzanne C. Crawley,Theodore R. Levin,Cynthia Reeves,Anna Schmitt,Michael Hepburn,Marvin H. Sleisenger,Young S. Kim +11 more
TL;DR: The detection of high-frequency MSI or the loss of MSH2 or MLH1 immunostaining in CRCs are both useful criteria for selecting high-risk patients who should be tested for germline mutations in MSH 2 orMLH1.
Journal ArticleDOI
Costs of Acid-related Disorders to a Health Maintenance Organization
Theodore R. Levin,Julie A. Schmittdiel,Kimberly Kunz,James M. Henning,Curtis J. Henke,Christopher J. Colby,Joseph V. Selby +6 more
TL;DR: Acid-related disorders, particularly GERD and PUD, contribute substantially to the direct costs of medical care in this managed care population and from the perspective of a large health maintenance organization (HMO).
Journal ArticleDOI
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review
Kevin Selby,Christine Baumgartner,Theodore R. Levin,Chyke A. Doubeni,Ann G Zauber,Joanne Schottinger,Christopher D. Jensen,Jeffrey K. Lee,Douglas A. Corley +8 more
TL;DR: In this paper, the authors evaluated interventions to improve rates of follow-up colonoscopy for adults after a positive result on a fecal test (guaiac or immunochemical).
Journal ArticleDOI
969 Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
Reinier G.S. Meester,Chyke A. Doubeni,Ann G. Zauber,Luuk Goede,Theodore R. Levin,Douglas A. Corley,Ahmedin Jemal,Iris Lansdorp-Vogelaar +7 more
Journal ArticleDOI
A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization
Theodore R. Levin,Julie A. Schmittdiel,James M. Henning,Kimberly Kunz,Curtis J. Henke,Christopher J. Colby,Joseph V. Selby +6 more
TL;DR: H. pylori treatment is associated with a decreased cost of follow-up care for patients with PUD, primarily due to decreased outpatient utilization.